<H2> 1-APR-1987 15:10:52.71</H2>
<H2>GENENTECH GENE SAYS FDA TO REVIEW TPA</H2>
Genentech Inc said Activase,
its tissue plasminogen activator, will be reviewed at the a
regularly scheduled May 29 meeting of the Food and Drug
Administration's cardiorenal advisory committee.
 
 